Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
01 Jul 2020
Entitlement Offer Cleansing Notice
01 Jul 2020
Capital Raising - Investor Presentation
01 Jul 2020
Entitlement Offer to Fund Phase 1 Clinical Trial
30 Jun 2020
Preclinical Toxicology Studies Support Phase1 Clinical Trial
29 Jun 2020
Trading Halt
25 Jun 2020
Full Year Statutory Accounts - YE 31 March 2020
02 Jun 2020
Investor Presentation
29 May 2020
Preliminary Final Report - YE 31 March 2020
19 May 2020
FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis
28 Apr 2020
Quarterly Activities Report - March 2020 Qtr
Previous
1
2
3
4
5
6
7
Next
